Shine Investment Advisory Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-61
Closed -$10K 791
2019
Q4
$10K Buy
+61
New +$11.3K ﹤0.01% 581
2019
Q1
Sell
-88
Closed -$29K 722
2018
Q4
$29K Buy
88
+67
+319% +$23.3K 0.01% 382
2018
Q3
$9K Sell
21
-11
-34% -$4.34K ﹤0.01% 538
2018
Q2
$13K Sell
32
-115
-78% -$41.7K 0.01% 499
2018
Q1
$43K Buy
+147
New +$37.3K 0.02% 337

Other funds holding ABMD

Shine Investment Advisory Services's ABMD Position: Q1 2020 in Review

Shine Investment Advisory Services sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 61 shares — an estimated $10K sold.

Shine Investment Advisory Services first reported a position in ABMD in Q1 2018 and held it in 5 quarters. The position peaked at $43K in Q1 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Shine Investment Advisory Services reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Shine Investment Advisory Services sold 61 Abiomed Inc shares in Q1 2020, an estimated $10K.
  • Shine Investment Advisory Services first reported a position in Abiomed Inc in Q1 2018 and held it in 5 quarters.
  • Shine Investment Advisory Services's Abiomed Inc position peaked at $43K in Q1 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Shine Investment Advisory Services's 13F filing for Q1 2020, filed 27 Apr 2020.